18322384|t|Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response.
18322384|a|BACKGROUND: Alzheimer's disease (AD) is characterized by beta-amyloid (Abeta) peptide-containing plaques and tau-containing neurofibrillary tangles. By intracerebral injection of Abeta(42), both pathologies have been combined in P301L tau mutant mice. Furthermore, in cell culture, Abeta(42) induces tau aggregation. While both Abeta(42) and mutant tau cause neuronal dysfunction, their modes of action are only vaguely understood. METHODS: To determine which processes are disrupted by Abeta(42) and/or P301L mutant tau, we used transcriptomic and proteomic techniques followed by functional validation and analysis of human AD tissue. RESULTS: Our transcriptomic study in the SH-SY5Y cell culture system revealed that Abeta(42) and P301L tau expression independently affect genes controlling the cell cycle and cell proliferation. Proteomics applied to Abeta(42)-treated P301L tau-expressing SH-SY5Y cells and the amygdala of Abeta(42)-injected P301L transgenic mice revealed that a significant fraction of proteins altered in both systems belonged to the same functional categories, i.e. stress response and metabolism. Among the proteins identified was valosin-containing protein (VCP), a component of the quality control system during endoplasmic reticulum stress. Mutations in VCP have recently been linked to frontotemporal dementia. CONCLUSION: Our data support the mitosis failure hypothesis that claims that aberrant cell cycle reentry of postmitotic neurons induces apoptosis. Furthermore, our data underline a role of Abeta(42) in the stress response associated with protein folding.
18322384	48	59	tauopathies	Disease	MESH:D024801
18322384	61	76	mitosis failure	Disease	MESH:D051437
18322384	120	139	Alzheimer's disease	Disease	MESH:D000544
18322384	141	143	AD	Disease	MESH:D000544
18322384	179	184	Abeta	Gene	351
18322384	217	220	tau	Gene	4137
18322384	232	255	neurofibrillary tangles	Disease	MESH:D055956
18322384	337	342	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
18322384	343	346	tau	Gene	4137
18322384	354	358	mice	Species	10090
18322384	390	399	Abeta(42)	Gene	351
18322384	408	411	tau	Gene	4137
18322384	436	445	Abeta(42)	Gene	351
18322384	457	460	tau	Gene	4137
18322384	467	487	neuronal dysfunction	Disease	MESH:D009461
18322384	595	604	Abeta(42)	Gene	351
18322384	612	617	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
18322384	625	628	tau	Gene	4137
18322384	728	733	human	Species	9606
18322384	734	736	AD	Disease	MESH:D000544
18322384	786	793	SH-SY5Y	CellLine	CVCL:0019
18322384	842	847	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
18322384	848	851	tau	Gene	4137
18322384	963	968	Abeta	Gene	351
18322384	981	986	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
18322384	987	990	tau	Gene	4137
18322384	1002	1009	SH-SY5Y	CellLine	CVCL:0019
18322384	1036	1041	Abeta	Gene	351
18322384	1055	1060	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
18322384	1072	1076	mice	Species	10090
18322384	1265	1291	valosin-containing protein	Gene	7415
18322384	1293	1296	VCP	Gene	7415
18322384	1391	1394	VCP	Gene	7415
18322384	1424	1447	frontotemporal dementia	Disease	MESH:D057180
18322384	1482	1497	mitosis failure	Disease	MESH:D051437
18322384	1638	1647	Abeta(42)	Gene	351
18322384	Association	351	4137
18322384	Positive_Correlation	MESH:D009461	351
18322384	Association	MESH:D057180	7415
18322384	Association	MESH:D009461	4137
18322384	Association	MESH:D000544	4137
18322384	Association	MESH:D055956	4137
18322384	Association	MESH:D000544	351

